Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-20

Clinical Trial Update: Management of Index Episode in Patients With Bipolar Disorder Treated by Seroquel XR

View source ↗

Summary

A completed clinical trial evaluating management of the index episode in bipolar disorder patients treated with Seroquel XR (quetiapine extended-release).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEROQUEL XR (Quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Bipolar Disorder, New Occurred Episode | Status: COMPLETED